Here's our Fast Money Final Trade. Our gang gives you Monday's best trades, right now!
Stocks ended relatively flat Friday after a disappointing GDP report but the Dow logged its best month in a year, rising more than 7 percent.
Stocks ended lower for a second day Thursday, led by tech and consumer shares, after some disappointing outlooks. Financial and materials rose slightly.
Stocks shaved some of their earlier losses as financials gained. Sony and BP shares rose.
The Dow pulled off its fourth-straight gain, led by DuPont after better-than-expected earnings from the chemicals maker. But the gain was more modest than in recent sessions as a drop in consumer confidence tempered investors' enthusiasm. Financials rose, while energy and consumer-discretionary stocks were among the weakest links.
Stocks struggled Tuesday as worries about a drop in consumer confidence offset better-than-expected result from DuPont. Energy and consumer discretionary were among the weakest sectors.
Stocks remained lower Tuesday amid revenue weakness in the latest round of earnings reports and another disappointing housing report. Goldman Sachs and IBM tumbled.
Here's what analysts and others say they're watching before the bell Tuesday.
Counterfeiters have created an international, multi-billion-dollar industry by making cheap imitations of designer goods and selling them for a fraction of the price.
Big pharmaceutical companies have been beaten down by worries over patent expirations, a lack of new products and low price-to-earnings ratios. But health care strategists aren't all pessimistic.
Excluding financials, US companies have racked up $1.7 trillion in cash leaving some investors hungry for their piece of the pie.
Here's what analysts and others say they're watching before the bell Monday.
Here's what analysts and others say they're watching before the bell Friday.
Which pharmaceutical company is reportedly preparing to spend $20 billion for a US drug maker?
In today's trading session, a total of 37 stocks in the S&P 500 reached a new 52-week low. Here is a look at those companies.
It has certainly been a forgettable quarter and a lackluster first half of the year for investors. With two trading sessions left in the quarter, U.S. stocks are on pace for their first quarterly decline since Q1 2009, snapping 4 straight quarters of gains.
Cramer makes the call on viewers' favorite stocks.
Stocks fell sharply as selling accelerated in the final hour of trading Thursday. Worries about a double-dip recession, financial reform and Greece weighed on the market.
Stocks shaved some of its losses in mid-afternoon trading Thursday, but worries about Greece and the financial reform continued to weigh on the market.
The Dow squeaked out a gain Wednesday after the Fed renewed its pledge to keep rates low and offered a statement with no surprises.